Medications That Increase Clozapine Levels
Strong CYP1A2 inhibitors—particularly fluvoxamine, ciprofloxacin, and enoxacin—dramatically increase clozapine levels and require dose reduction to one-third of the original dose when co-administered. 1
CYP1A2 Inhibitors (Most Clinically Significant)
Strong Inhibitors
- Fluvoxamine: Increases clozapine levels by 263% 2 and requires reducing clozapine dose to one-third 1
- Ciprofloxacin: Requires reducing clozapine dose to one-third 1
- Enoxacin: Requires reducing clozapine dose to one-third 1
Moderate/Weak Inhibitors
- Oral contraceptives: Monitor closely and consider dose reduction 1
- Caffeine: Monitor closely and consider dose reduction 1
CYP2D6 Inhibitors
These medications increase clozapine levels with varying effect sizes:
- Fluoxetine: Increases levels by 42-58% 2, 3; dose-correction factor 0.70 2
- Paroxetine: Increases levels by 30-31% 2, 4; dose-correction factor 0.77 2
- Bupropion: Can increase clozapine levels 1
- Duloxetine: Can increase clozapine levels 1
- Quinidine: Can increase clozapine levels 1
- Terbinafine: Can increase clozapine levels 1
CYP3A4 Inhibitors
- Erythromycin: Can increase clozapine levels 1
- Cimetidine: Can increase clozapine levels 1
- Escitalopram: Can increase clozapine levels 1
Sertraline: Minimal Effect
Sertraline does not significantly affect clozapine levels at typical therapeutic doses (50-100 mg/day) and can be added safely without dose adjustment. 4 This contrasts with other SSRIs and makes it a preferred antidepressant choice when co-prescribing with clozapine.
Valproic Acid: Complex Interaction
Valproic acid has a bidirectional effect depending on smoking status 2:
- Non-smokers: Inhibits metabolism (+16% increase); dose-correction factor 0.86
- Smokers: Induces metabolism (-22% decrease); dose-correction factor 1.3
This interaction is clinically significant because smoking itself reduces clozapine levels by 20% in non-valproate users and 46% in valproate users 2.
Clinical Monitoring Recommendations
When adding CYP inhibitors to clozapine:
Monitor clozapine levels when adding or discontinuing any CYP1A2, CYP2D6, or CYP3A4 inhibitor 5
Check levels with:
- Change in co-medications
- Increased sedation or myoclonus
- Change in mental state
- Infection/inflammatory illness 5
Watch for toxicity signs: Sedation, myoclonus, seizures, hypersalivation, tachycardia 1
Critical Pitfalls
- Fluvoxamine co-administration without dose reduction is the most dangerous interaction—can increase levels nearly 4-fold 2
- Assuming all SSRIs behave similarly—sertraline is safe while fluoxetine and paroxetine require monitoring 6, 4
- Ignoring smoking status when prescribing valproic acid—the interaction reverses direction 2
- Failing to reduce clozapine dose when discontinuing enzyme inducers can cause toxicity 1